ONCY
Oncolytics Biotech·NASDAQ
--
--(--)
--
--(--)
ONCY Filings
Filing Date
Form Description
Form Type
2025-12-16
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-16 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-10
Form EFFECT - Notice of Effectiveness
2025-12-10 ·
Form EFFECT - Notice of Effectiveness
2025-12-10
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-10 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-09
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-09 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-05
Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]
2025-12-05 ·
Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]
2025-11-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-11-12 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-04
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-04 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
